AIMS: Previous research has reported that both contingency management (CM) and cognitive-behavioral therapy (CBT) are efficacious interventions for the treatment of stimulant abusers. The present study sought to directly compare the effectiveness of (CM) and (CBT) alone and in combination in reducing stimulant use. DESIGN: Randomized clinical trial. PARTICIPANTS: Stimulant-dependent individuals (n = 171). INTERVENTION: CM, CBT or combined CM and CBT, 16-week treatment conditions. CM condition participants received vouchers for stimulant-free urine samples. CBT condition participants attended three 90-minute group sessions each week. MEASUREMENTS: Participants were interviewed at baseline and weeks 17, 26 and 52. Measures included psychiatric disorders and alcohol and drug use and concomitant social problems. FINDINGS: CM procedures produced better retention and lower rates of stimulant use during the study period. Self-reported stimulant use was reduced from baseline levels at all follow-up points for all groups and urinalysis data did not differ between groups at follow-up. While CM produced robust evidence of efficacy during treatment application, CBT produced comparable longer-term outcomes. There was no evidence of an additive effect when the two treatments were combined. CONCLUSIONS: This study suggests that CM is an efficacious treatment for reducing stimulant use and is superior during treatment to a CBT approach. CM is useful in engaging substance abusers, retaining them in treatment and helping them achieve abstinence from stimulant use. CBT also reduces drug use from baseline levels and produces comparable outcomes on all measures at follow-up.
RCT Entities:
AIMS: Previous research has reported that both contingency management (CM) and cognitive-behavioral therapy (CBT) are efficacious interventions for the treatment of stimulant abusers. The present study sought to directly compare the effectiveness of (CM) and (CBT) alone and in combination in reducing stimulant use. DESIGN: Randomized clinical trial. PARTICIPANTS: Stimulant-dependent individuals (n = 171). INTERVENTION: CM, CBT or combined CM and CBT, 16-week treatment conditions. CM condition participants received vouchers for stimulant-free urine samples. CBT condition participants attended three 90-minute group sessions each week. MEASUREMENTS: Participants were interviewed at baseline and weeks 17, 26 and 52. Measures included psychiatric disorders and alcohol and drug use and concomitant social problems. FINDINGS: CM procedures produced better retention and lower rates of stimulant use during the study period. Self-reported stimulant use was reduced from baseline levels at all follow-up points for all groups and urinalysis data did not differ between groups at follow-up. While CM produced robust evidence of efficacy during treatment application, CBT produced comparable longer-term outcomes. There was no evidence of an additive effect when the two treatments were combined. CONCLUSIONS: This study suggests that CM is an efficacious treatment for reducing stimulant use and is superior during treatment to a CBT approach. CM is useful in engaging substance abusers, retaining them in treatment and helping them achieve abstinence from stimulant use. CBT also reduces drug use from baseline levels and produces comparable outcomes on all measures at follow-up.
Authors: Tracy L Greer; Kolette M Ring; Diane Warden; Bruce D Grannemann; Timothy S Church; Eugene Somoza; Steven N Blair; Jose Szapocznik; Mark Stoutenberg; Chad Rethorst; Robrina Walker; David W Morris; Andrzej S Kosinski; Tiffany Kyle; Bess Marcus; Becca Crowell; Neal Oden; Edward Nunes; Madhukar H Trivedi Journal: J Glob Drug Policy Pract Date: 2012
Authors: Radha Rajasingham; Matthew J Mimiaga; Jaclyn M White; Megan M Pinkston; Rachel P Baden; Jennifer A Mitty Journal: AIDS Patient Care STDS Date: 2011-11-09 Impact factor: 5.078
Authors: Richard A Rawson; Joy Chudzynski; Larissa Mooney; Rachel Gonzales; Alfonso Ang; Daniel Dickerson; Jose Penate; Bilal A Salem; Brett Dolezal; Christopher B Cooper Journal: Drug Alcohol Depend Date: 2015-09-03 Impact factor: 4.492
Authors: Catherine E Oldenburg; Jennifer A Mitty; Katie B Biello; Elizabeth F Closson; Steven A Safren; Kenneth H Mayer; Matthew J Mimiaga Journal: AIDS Behav Date: 2016-07
Authors: Matthew J Mimiaga; Sari L Reisner; David W Pantalone; Conall O'Cleirigh; Kenneth H Mayer; Steven A Safren Journal: AIDS Patient Care STDS Date: 2012-10-03 Impact factor: 5.078
Authors: Karen F Corsi; Wayne E Lehman; Sung-Joon Min; Shannon P Lance; Nicole Speer; Robert E Booth; Steve Shoptaw Journal: J AIDS Clin Res Date: 2012-06-04
Authors: Thomas F Newton; Malcolm S Reid; Richard De La Garza; James J Mahoney; Antonio Abad; Rany Condos; Joseph Palamar; Perry N Halkitis; Jurji Mojisak; Ann Anderson; Shou-Hua Li; Ahmed Elkashef Journal: Int J Neuropsychopharmacol Date: 2008-07-29 Impact factor: 5.176